Aspects of pharmacology in the neonatal foal.

This research explores the nuances of pharmacological treatment in newborn horses, emphasizing the critical role of species, age, and maturity when determining drug dosage and frequency of administration. It further provides recommendations on appropriate medication selection and delivery methods in neonate animals.

Significance of Age, Species and Maturity in Neonate Pharmacology

• The pharmacological research indicates that species, age, and the level of maturity significantly affect drug metabolism in newborn creatures, highlighting the inherent risk of drawing pharmacological parallels between different species. Therefore, it underscores the importance of acquiring foal-specific data and the necessity of monitoring drug levels in individual subjects.

Recommendations for Pharmacological Treatment in Neonates

The study provided several key recommendations for neonatal medication:

• It advised against administering unnecessary drugs to the dam during delivery to prevent potential adverse impacts on the neonate due to possible placental drug transfer.
• It proposed avoiding unnecessary drug therapy in foals that are less than 30 days old, when feasible.
• The research suggested selecting drugs with minimal biotransformation and not heavily protein-bound.

Crucial Aspects to Consider in Disease Treatment

Several considerations were outlined when dealing with life-threatening infections:

• Due to a likely immune deficiency in the neonate, the use of broad-spectrum, bactericidal drugs was recommended.
• The study also emphasized identifying the disease-causing agent to base the pharmacological treatment on culture and sensitivity test results. This strategical approach could maximize the benefit-risk ratio.

Recommendations on Drug Administration Strategies

The research article also tackled drug administration specifics:

• It advocated for parenteral (intramuscular or intravenous) drug administration over oral intake.
• It advised avoidance of drugs identified as oxidants that may lead to hemolysis or methemoglobinemia.
• The research generally recommended using the same or slightly higher initial dose for neonates, while administering less frequently than in adults if the drug carries a high toxicity risk.
• In case of potentially toxic drugs, the paper proposed the individual monitoring of serum levels in premature and newborn foals, unless specific drug pharmacokinetics are known for that age group.